These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 1643642)
1. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cerny WL; Mangold KA; Scarpelli DG Cancer Res; 1992 Aug; 52(16):4507-13. PubMed ID: 1643642 [TBL] [Abstract][Full Text] [Related]
2. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563 [TBL] [Abstract][Full Text] [Related]
3. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters. Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455 [TBL] [Abstract][Full Text] [Related]
4. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983 [TBL] [Abstract][Full Text] [Related]
5. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma. Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083 [TBL] [Abstract][Full Text] [Related]
6. Orotic acid enhancement of preneoplastic and neoplastic lesions induced in the pancreas and liver of hamsters by N-nitroso(2-hydroxypropyl) (2-oxopropyl)amine. Kokkinakis DM; Albores-Saavedra J Cancer Res; 1994 Oct; 54(20):5324-32. PubMed ID: 7923160 [TBL] [Abstract][Full Text] [Related]
7. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602 [TBL] [Abstract][Full Text] [Related]
8. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941 [TBL] [Abstract][Full Text] [Related]
9. K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines. Erill N; Cuatrecasas M; Sancho FJ; Farré A; Pour PM; Lluís F; Capellá G Am J Pathol; 1996 Oct; 149(4):1333-9. PubMed ID: 8863680 [TBL] [Abstract][Full Text] [Related]
10. K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654 [TBL] [Abstract][Full Text] [Related]
11. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers. Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617 [TBL] [Abstract][Full Text] [Related]
12. K-ras gene mutations in intrahepatic bile duct tumors of Syrian golden hamsters. Yamanaka S; Tomioka T; Tajima Y; Okada K; Shiku H; Kanematsu T J Surg Oncol; 1997 Oct; 66(2):97-103. PubMed ID: 9354164 [TBL] [Abstract][Full Text] [Related]
13. Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor. Takahashi M; Kitahashi T; Ishigamori R; Mutoh M; Komiya M; Sato H; Kamanaka Y; Naka M; Maruyama T; Sugimura T; Wakabayashi K Carcinogenesis; 2008 Aug; 29(8):1608-13. PubMed ID: 18567618 [TBL] [Abstract][Full Text] [Related]
14. Experimental pancreatic carcinogenesis. I. Morphogenesis of pancreatic adenocarcinoma in the Syrian golden hamster induced by N-nitroso-bis(2-hydroxypropyl)amine. Levitt MH; Harris CC; Squire R; Springer S; Wenk M; Mollelo C; Thomas D; Kingsbury E; Newkirk C Am J Pathol; 1977 Jul; 88(1):5-28. PubMed ID: 327823 [TBL] [Abstract][Full Text] [Related]
15. Bile-reflux into the pancreatic ducts is associated with the development of intraductal papillary carcinoma in hamsters. Adachi T; Tajima Y; Kuroki T; Mishima T; Kitasato A; Fukuda K; Tsutsumi R; Kanematsu T J Surg Res; 2006 Nov; 136(1):106-11. PubMed ID: 16863651 [TBL] [Abstract][Full Text] [Related]
16. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Qian J; Niu J; Li M; Chiao PJ; Tsao MS Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547 [TBL] [Abstract][Full Text] [Related]
17. Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats. van Kranen HJ; Vermeulen E; Schoren L; Bax J; Woutersen RA; van Iersel P; van Kreijl CF; Scherer E Carcinogenesis; 1991 Aug; 12(8):1477-82. PubMed ID: 1860169 [TBL] [Abstract][Full Text] [Related]
18. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing. Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449 [TBL] [Abstract][Full Text] [Related]
19. [Molecular pathways of pancreatic carcinogenesis]. Torrisani J; Buscail L Ann Pathol; 2002 Oct; 22(5):349-55. PubMed ID: 12483152 [TBL] [Abstract][Full Text] [Related]